Biofrontera Ag Company Profile (LON:B8F)

About Biofrontera Ag

Biofrontera Ag logo

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: B8F
  • CUSIP:
Key Metrics:
  • Previous Close: $0.00
  • 50 Day Moving Average: $
  • 200 Day Moving Average: $
  • Trailing P/E Ratio:
  • P/E Growth:
  • Market Cap: $
Additional Links:

Analyst Ratings

Consensus Ratings for Biofrontera Ag (LON:B8F) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Biofrontera Ag (LON:B8F)
Show:
DateFirmActionRatingPrice TargetDetails
2/17/2016Shore CapitalReiterated Ratinghouse stockView Rating Details
4/10/2015FinnCapReiterated RatingUnder ReviewView Rating Details
(Data available from 2/25/2015 forward)

Earnings

Earnings History for Biofrontera Ag (LON:B8F)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Biofrontera Ag (LON:B8F)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Biofrontera Ag (LON:B8F)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Biofrontera Ag (LON:B8F)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Biofrontera Ag (LON:B8F)
DateHeadline
News IconBiofrontera AG: Biofrontera Initiates U.S. Commercial Launch of Ameluz® for Actinic Keratosis (LON:B8F)
www.pressetext.com - October 19 at 8:39 AM
News IconBiofrontera AG: Biofrontera to Present at the Dawson James Securities 2nd Annual Growth Stock Conference (LON:B8F)
www.pressetext.com - October 7 at 3:42 PM
News IconPTA-News: Biofrontera AG: Biofrontera präsentiert auf der Dawson James Annual Growth Stock Conference (LON:B8F)
www.bioportfolio.com - October 7 at 3:42 PM
4-traders.com logoBiofrontera : Receives Label Expansion for Ameluz® in Europe to Include Field Cancerization (LON:B8F)
www.4-traders.com - September 17 at 8:33 AM
News IconBiofrontera AG: Biofrontera Receives Label Expansion for Ameluz® in Europe to Include Field Cancerization (LON:B8F)
www.pressetext.com - September 17 at 8:33 AM
News IconBiofrontera AG: Biofrontera Reports Financial Results and Business Update for Second Quarter and First Half 2016 (LON:B8F)
www.pressetext.com - August 31 at 3:41 PM
News IconPTA-News: Biofrontera AG: Biofrontera Reports Financial Results and Business Update for Second Quarter and First Half 2016 (LON:B8F)
www.onvista.de - August 31 at 8:33 AM
News IconBiofrontera AG: Biofrontera to Present at the 18th Annual Rodman & Renshaw Global Investment Conference (LON:B8F)
www.pressetext.com - August 30 at 9:34 AM
4-traders.com logoBiofrontera : präsentiert auf der 18. Rodman & Renshaw Global Investment Konferenz (LON:B8F)
www.4-traders.com - August 30 at 9:34 AM
News IconBiofrontera AG: Biofrontera Accelerates Production of BF-RhodoLED® Lamps to Prepare for U.S. Commercial Launch (LON:B8F)
www.pressetext.com - August 26 at 3:40 PM
News IconPTA-News: Biofrontera AG: Biofrontera Accelerates Production of BF-RhodoLED® Lamps to Prepare for U.S. Commercial Launch (LON:B8F)
www.onvista.de - August 26 at 3:40 PM
4-traders.com logoBiofrontera : Notice of half-year report of 2016 (LON:B8F)
www.4-traders.com - August 25 at 3:45 PM
News IconPTA-News: Biofrontera AG: Notice of half-year report of 2016 (LON:B8F)
www.onvista.de - August 25 at 3:45 PM
News IconBiofrontera AG: Notice of half-year report of 2016 (LON:B8F)
www.pressetext.com - August 25 at 3:45 PM
live-pr.com logoBiofrontera AG (B8F) - Financial and Strategic SWOT Analysis Review - New Report Available (LON:B8F)
www.live-pr.com - August 4 at 3:49 PM
4-traders.com logoBiofrontera : Receives Favourable CHMP Assessment for Field-Directed Therapy and Files BCC Application (LON:B8F)
www.4-traders.com - July 28 at 12:28 PM
News IconBiofrontera AG: Biofrontera Receives Favourable CHMP Assessment for Field-Directed Therapy and Files BCC Application (LON:B8F)
www.pressetext.com - July 28 at 12:28 PM
News IconPTA-News: Biofrontera AG: Biofrontera to Present at the Canaccord Genuity Annual Growth Conference (LON:B8F)
www.onvista.de - July 25 at 8:31 AM
News IconBiofrontera AG: Biofrontera to Present at the Canaccord Genuity Annual Growth Conference (LON:B8F)
www.pressetext.com - July 25 at 8:31 AM
4-traders.com logoAd-hoc: Biofrontera AG and Maruho Initiate Joint Project to Explore Development Opportunities (LON:B8F)
www.4-traders.com - July 13 at 9:10 PM
4-traders.com logoBiofrontera : Initiates Phase III Trial of Ameluz® in Combination with Daylight-PDT (LON:B8F)
www.4-traders.com - June 30 at 9:08 PM
News IconBiofrontera AG: Biofrontera Progresses with Expansion of U.S. Subsidiary with Key Personnel Hires (LON:B8F)
www.pressetext.com - June 23 at 11:10 PM
4-traders.com logoBiofrontera : Progresses with Expansion of U.S. Subsidiary with Key Personnel Hires (LON:B8F)
www.4-traders.com - June 23 at 11:10 PM
News IconBiofrontera AG: Biofrontera Reports First Quarter 2016 Financial Results and Business Update (LON:B8F)
www.pressetext.com - May 26 at 5:06 PM
publicnow.com logoNotice of quarterly report of 2016 (LON:B8F)
www.publicnow.com - May 23 at 2:36 AM
finance.yahoo.com logoBiofrontera AG: Notice of Annual Results 2016 (LON:B8F)
finance.yahoo.com - April 7 at 8:02 AM
News IconPTA-News: Biofrontera AG: Results of Phase III clinical trial evaluating BF-200 ALAfor treatment of basal cell carcinoma (BCC) (LON:B8F)
www.finanzen.ch - March 5 at 2:52 PM
News IconPTA-PVR : Nexus AG: Release according to Article 26, Section 1 of the WpHG (LON:B8F)
www.onvista.de - February 16 at 2:55 PM
4-traders.com logoBiofrontera : AG: AG resolves on capital increase (LON:B8F)
www.4-traders.com - February 16 at 2:55 PM
thestreet.com logoBiofrontera AG: Biofrontera AG Resolves On Capital Increase (LON:B8F)
www.thestreet.com - February 16 at 2:55 PM
News IconBiofrontera AG: Data from pivotal Phase III studies with BF-200 ALA introduced to US dermtologists (LON:B8F)
www.pressetext.com - February 11 at 2:45 PM
thestreet.com logoBiofrontera AG: Pivotal Phase III Data Demonstrate Significant Efficacy And Excellent Safety For BF-200 ALA Treatment Of Superficial Skin Cancer (LON:B8F)
www.thestreet.com - February 11 at 2:45 PM
News IconPTA-Adhoc: Biofrontera AG: Biofrontera's Ameluz® achieves excellent results in clinical study for basal cell carcinoma (LON:B8F)
www.onvista.de - January 28 at 2:53 PM
trustnet.com logoFDA completes mid-cylce review of Biofrontera's Ameluz (LON:B8F)
www.trustnet.com - January 27 at 2:22 PM
noodls.com logoBiofrontera AG Notice of Third Quarter Results 2015 (LON:B8F)
www.noodls.com - November 12 at 8:06 AM
noodls.com logoBiofrontera AG Notice of First Half Year Results 2015 (LON:B8F)
www.noodls.com - August 7 at 2:06 AM
finance.yahoo.com logoBiofrontera AG: Notice of First Half Year Results 2015 (LON:B8F)
finance.yahoo.com - August 7 at 2:01 AM
noodls.com logoNotice of First Quarter Results 2015 (LON:B8F)
www.noodls.com - May 22 at 10:30 AM
finance.yahoo.com logoBiofrontera AG: Notice of First Quarter Results 2015 (LON:B8F)
finance.yahoo.com - May 22 at 10:19 AM
noodls.com logoNotice of Annual Results 2014 (LON:B8F)
www.noodls.com - March 30 at 2:00 AM

Social

What is Biofrontera Ag's stock symbol?

Biofrontera Ag trades on the London Stock Exchange (LON) under the ticker symbol "B8F."

How do I buy Biofrontera Ag stock?

Shares of Biofrontera Ag and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How much does a share of Biofrontera Ag stock cost?

One share of Biofrontera Ag stock can currently be purchased for approximately GBX 145.


Last Updated on 2/25/2017 by MarketBeat.com Staff